text_1: The treatment of cancer patients with co-IR blockade does not cause any adverse autoimmune events.
text_2: In this Perspective, we discuss evidence that the occurrence of immunotoxicity bodes well for the patient, and describe mechanisms that might be related to the induction of autoimmunity.